Ironwood Pharmaceuticals ...

AI Score

0

Unlock

3.65
-0.12 (-3.18%)
At close: Jan 14, 2025, 3:59 PM
3.65
-0.14%
After-hours Jan 14, 2025, 04:38 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Revenue 442.74M 410.60M 413.75M 389.52M 428.41M 346.64M 298.28M 273.96M 149.56M 76.44M 22.88M 150.25M 65.87M 43.86M 36.10M 22.22M 10.46M 3.14M
Cost of Revenue 104.78M 1.42M 1.52M 3.14M 23.88M 32.75M 19.41M 1.87M 12.00K 25.58M 7.20M 965.00K n/a n/a n/a n/a n/a 3.14M
Gross Profit 337.95M 409.18M 412.23M 386.39M 404.54M 313.89M 278.87M 272.09M 149.54M 50.85M 15.68M 149.28M 65.87M 43.86M 36.10M 22.22M 10.46M n/a
Operating Income -945.43M 250.34M 232.26M 142.94M 120.12M -238.89M -77.39M -51.87M -102.09M -169.37M -252.00M -72.76M -66.14M -60.77M -72.77M -55.92M -57.62M -39.59M
Interest Income 18.97M 9.50M 726.00K 1.50M 2.86M 2.99M 2.11M 1.17M 443.00K 257.00K 192.00K 197.00K 456.00K 614.00K 243.00K 2.12M 4.12M 2.53M
Pretax Income -948.07M 252.42M 200.66M 108.86M 58.94M -282.37M -116.94M -81.71M -142.67M -189.62M -272.81M -72.62M -64.85M -59.35M -73.61M -55.03M -53.16M -37.28M
Net Income -1.00B 175.06M 528.45M 106.18M -15.31M -282.37M -116.94M -81.71M -142.67M -189.62M -272.81M -72.62M -64.85M -52.98M -71.19M -53.87M -52.75M -37.18M
Selling & General & Admin 158.31M 115.99M 111.13M 140.00M 172.45M 241.29M 233.12M 173.28M 125.25M 118.33M 123.23M 92.54M 45.92M 27.17M 23.98M 18.33M 10.83M 5.93M
Research & Development 116.08M 44.27M 70.41M 88.06M 115.04M 166.50M 148.23M 139.49M 108.75M 101.89M 102.38M 113.47M 86.09M 77.45M 84.89M 59.81M 57.25M 35.54M
Other Expenses 1.01B n/a n/a 24.00K 514.00K 8.11M 6.21M 981.00K 17.64M 661.00K 42.07M 16.03M n/a n/a 23.98M 18.33M 10.83M n/a
Operating Expenses 1.28B 160.26M 181.54M 228.06M 287.49M 415.90M 387.56M 313.75M 233.99M 220.22M 267.68M 222.04M 132.01M 104.62M 108.87M 78.14M 68.08M 41.48M
Interest Expense 21.63M 7.60M 31.15M 29.48M 36.60M 34.73M 34.26M 37.98M 30.65M 21.17M 21.00M 59.00K 63.00K 196.00K 474.00K 334.00K 263.00K 217.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 1.39B 160.26M 181.54M 231.20M 311.37M 448.66M 406.97M 315.62M 234.00M 245.81M 274.88M 223.01M 132.01M 104.62M 108.87M 78.14M 68.08M 42.73M
Income Tax 83.49M 77.36M -327.79M 2.69M 74.26M -5.75M 34.26M 37.98M 19.02M 8.58M -11.73M -11.32M 3.00K -2.94M -296.00K -823.00K -145.00K n/a
Shares Outstanding (Basic) 155.44M 154.37M 162.25M 159.43M 156.02M 152.63M 148.42M 144.93M 142.16M 136.81M 115.85M 106.40M 99.88M 89.65M 7.12M 6.89M 7.12M 94.91M
Shares Outstanding (Diluted) 155.44M 186.31M 164.42M 160.66M 156.02M 152.63M 148.99M 145.91M 142.16M 136.81M 115.85M 106.40M 99.88M 89.65M 75.57M 6.89M 75.57M 94.91M
EPS (Basic) -6.45 1.13 3.26 0.67 -0.1 -1.85 -0.79 -0.56 -1 -1.39 -2.35 -0.68 -0.65 -0.59 -10 -7.82 -7.41 -0.39
EPS (Diluted) -6.45 0.94 3.21 0.66 -0.1 -1.85 -0.78 -0.56 -1 -1.39 -2.35 -0.68 -0.65 -0.59 -0.94 -7.82 -0.7 -0.39
EBITDA -924.86M 261.44M 233.33M 141.90M 101.13M -144.45M -33.12M -31.30M -99.94M -156.12M -240.08M -61.24M -54.79M -53.00M -67.28M -51.85M -51.17M -35.80M
Depreciation & Amortization 1.57M 1.42M 1.52M 3.56M 5.58M 11.97M 14.62M 11.26M 11.63M 12.33M 11.73M 11.32M 10.00M 6.16M 5.25M 2.85M 1.73M 1.26M